Unilateral axillary lymphadenopathy is a frequent mild side effect of COVID-19 vaccination.
European Society of Breast Imaging (EUSOBI) proposes ten recommendations to …

Introduction: Following vaccination of Israeli population with Pfizer-BioNTech COVID-19
Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses …

Please see the Editorial Comment by Hannah Perry discussing this article. To listen to the
podcast associated with this article, please select one of the following: iTunes, Google Play …

Early clinical experience with COVID-19 vaccination suggests that approved COVID-19
vaccines cause a notably higher incidence of axillary lymphadenopathy on breast MRI …

Reports of patients with axillary adenopathy identified on breast imaging after coronavirus
disease (COVID-19) vaccination are rising. We propose a pragmatic management approach …

Background Axillary lymph node characteristics on axillary ultrasound (US), breast MRI and
18F-FDG PET/CT are relevant at breast cancer diagnosis. Axillary lymphadenopathy after …

Axillary lymphadenopathy caused by the high immunogenicity of messenger RNA (mRNA)
COVID-19 vaccines presents radiologists with new diagnostic dilemmas in differentiating …

We present a multimodality pictorial review of axillary lymphadenopathy in patients recently
vaccinated against COVID-19. As the mass vaccination programme continues to be rolled …

Abstract Purpose Lymphadenopathy (LAP) after COVID-19 vaccination in patients with a
diagnosis of cancer has been challenging. We analyzed imaging and clinical features from …

There have been recent reports in the breast imaging literature of unilateral axillary
lymphadenopathy following COVID-19 vaccination. It is unclear whether the reactive …